Opko Health (OPK) Gross Margin (2010 - 2026)
Opko Health's (OPK) quarterly Gross Margin came in at 48.92% in Q2 2026, up 1741.0% YoY from 2.66% in Q2 2025, and up 32.78% on a QoQ basis from 36.84% in Q1 2026.
Opko Health (OPK) Gross Margin (2010 - 2026) Analysis & Trends
Opko Health (OPK) has 17 years of Gross Margin data on file, last reported at 48.92% in Q2 2026.
- Quarterly Gross Margin rose 1741.0% year-over-year to 48.92% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 40.77% (up 944.0% YoY) and the FY2025 annual result came in at 33.93%, up 329.0% from the prior year.
- Gross Margin improved to 48.92% in Q2 2026, from 36.84% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 57.42% in Q2 2023 to a low of 4462.36% in Q1 2023.
- A 5-year average of 234.26% and a median of 31.5% in 2025 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin plunged 449517 bps — and 2024, when it soared 448658 bps.
- Tracing OPK's Gross Margin over 5 years: stood at 5.08% in 2022, then slumped by 225 bps to 16.49% in 2023, then soared by 253 bps to 25.28% in 2024, then jumped by 71 bps to 43.13% in 2025, then increased by 13 bps to 48.92% in 2026.
- The last three Gross Margin figures came in at 48.92% (Q2 2026), 36.84% (Q1 2026), and 43.13% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 69.57% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 57.64% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 64.58% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 53.95% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 32.85% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 64.04% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 66.44% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 63.29% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 29.80% |
| 10 | Opko Health | 1.13 Bn | 824.59 Mn | 80.02 Mn | 48.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.92% |
| Mar 31, 2026 | 36.84% |
| Dec 31, 2025 | 43.13% |
| Sep 30, 2025 | 32.90% |
| Jun 30, 2025 | 31.50% |
| Mar 31, 2025 | 28.42% |
| Sep 30, 2024 | 25.28% |
| Jun 30, 2024 | 26.34% |
| Mar 31, 2024 | 24.22% |
| Dec 31, 2023 | -16.49% |
| Sep 30, 2023 | 40.44% |
| Jun 30, 2023 | 57.42% |
| Mar 31, 2023 | -4,462.36% |
| Dec 31, 2022 | -5.08% |
| Sep 30, 2022 | 28.69% |
| Jun 30, 2022 | 44.55% |
| Mar 31, 2022 | 32.81% |
| Dec 31, 2021 | 32.29% |
| Sep 30, 2021 | 42.15% |
| Jun 30, 2021 | 39.47% |